Roche, announced that it has entered into a definitive merger agreement to acquire 89bio, a publicly listed clinical-stage biopharmaceutical company pioneering the development of...
Servier has entered into a definitive agreement with Kaerus Bioscience to acquire KER-0193, a potential first-in-disease treatment for Fragile X syndrome (FXS), the leading...
BullFrog AI Holdings, a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics,...
SOPHiA GENETICS a global leader in data-driven medicine and cloud-native healthcare technology, announced a new collaboration with Jessa Ziekenhuis, one of Belgium’s largest healthcare...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
